Chiron Capital Management’s Labcorp LH Stock Holding History

Chiron Capital Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-116	Closed	-$19K	–	271
2020 Q3	$19K	Buy	+116	New	+$18.4K	0.02%	231

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Chiron Capital Management's LH Position: Q4 2020 in Review

Chiron Capital Management sold out of Labcorp (LH) in Q4 2020, closing a stake of 116 shares — an estimated $19K sold.

Chiron Capital Management first reported a position in LH in Q3 2020 and held it in 1 quarter. The position peaked at $19K in Q3 2020. 906 funds tracked by Wall St. Rank hold LH as of Q4 2020.

Chiron Capital Management reported no remaining Labcorp position as of Q4 2020 after selling out during the quarter.
Chiron Capital Management sold 116 Labcorp shares in Q4 2020, an estimated $19K.
Chiron Capital Management first reported a position in Labcorp in Q3 2020 and held it in 1 quarter.
Chiron Capital Management's Labcorp position peaked at $19K in Q3 2020.
906 funds tracked by Wall St. Rank held Labcorp as of Q4 2020.

Based on Chiron Capital Management's 13F filing for Q4 2020, filed 5 Mar 2021.